A partially degraded product of phytate suppresses the proliferation of HCT116 colorectal cancer cells

被引:7
|
作者
Ishizuka, Satoshi [1 ]
Saitoh, Ken-ichi [1 ]
Suzuki, Takuya [1 ]
Lee, Jae-Sung [1 ]
Hara, Hiroshi [1 ]
机构
[1] Hokkaido Univ, Res Fac Agr, Div Appl Biosci, Kita Ku, Sapporo, Hokkaido 0608589, Japan
基金
日本学术振兴会;
关键词
Cell proliferation; 5 bromo 2 ' deoxyuridine; HCT116; cells; Phytate hydrolysate; INOSITOL HEXAPHOSPHATE IP6; PHYTIC ACID IP6; WILD-TYPE P53; SMALL-INTESTINE; DNA-DAMAGE; APOPTOSIS; PROTEIN; HUMANS; INHIBITION; HYDROLYSIS;
D O I
10.1016/j.foodchem.2010.10.037
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Phytate myo inositol hexaphosphate (IP6) has been shown to possess anti-carcinogenic qualities IP6 appears to be partially digested in the digestive tract and degraded into inositol di tri- and tetraphosphate (IP2 IP3 and IP4) The present study investigated whether IP3-rich phytate hydrolysate (IP3-RPH) a partially degraded product from phytate plays a role in the suppression of cell proliferation using an HCT116 colon carcinoma cell line IP3-RPH suppresses cell proliferation as does IP6 and the suppression activity of IP3-RPH is higher than that of IP6 Suppression modes clearly differed between IP3-RPH and IP6 Our findings suggest that partially degraded IP6 products are responsible for the suppression of colon carcinogenesis by IP6 (C) 2010 Elsevier Ltd All rights reserved
引用
收藏
页码:1219 / 1225
页数:7
相关论文
共 50 条
  • [21] Effect of hydroxyapatite particle size, morphology and crystallinity on proliferation of colon cancer HCT116 cells
    Dey, Sangeeta
    Das, Mitun
    Balla, Vamsi Krishna
    MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2014, 39 : 336 - 339
  • [22] Zerumbone reduces proliferation of HCT116 colon cancer cells by inhibition of TNF-alpha
    Salam Pradeep Singh
    Khumukcham Nongalleima
    Ningthoujam Indrajit Singh
    Pradip Doley
    Chingakham Brajakisor Singh
    Thiyam Ramsing Singh
    Dinabandhu Sahoo
    Scientific Reports, 8
  • [23] Columbianadin Inhibits Cell Proliferation by Inducing Apoptosis and Necroptosis in HCT116 Colon Cancer Cells
    Kang, Ji In
    Hong, Ji-Young
    Choi, Jae Sue
    Lee, Sang Kook
    BIOMOLECULES & THERAPEUTICS, 2016, 24 (03) : 320 - 327
  • [24] Zerumbone reduces proliferation of HCT116 colon cancer cells by inhibition of TNF-alpha
    Singh, Salam Pradeep
    Nongalleima, Khumukcham
    Singh, Ningthoujam Indrajit
    Doley, Pradip
    Singh, Chingakham Brajakisor
    Singh, Thiyam Ramsing
    Sahoo, Dinabandhu
    SCIENTIFIC REPORTS, 2018, 8
  • [25] 42 and 44°C Hyperthermia Induces Gene Amplification in Colorectal Cancer HCT116 Cells
    Yan, B.
    Neill, D. M.
    Liu, T.
    Dewhirst, M. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S701 - S701
  • [26] Effects of Enterococcus faecalis-derived Gelatinase E on HCT116 colorectal cancer cells
    Henstra, C.
    Fadavizad, K.
    Van Praagh, J.
    Olinga, P.
    Nagelkerke, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2143 - I2143
  • [27] Solubilized antigen of Blastocystis hominis facilitates the growth of human colorectal cancer cells, HCT116
    Samudi Chandramathi
    Kumar Suresh
    Umah Rani Kuppusamy
    Parasitology Research, 2010, 106 : 941 - 945
  • [28] Solubilized antigen of Blastocystis hominis facilitates the growth of human colorectal cancer cells, HCT116
    Chandramathi, Samudi
    Suresh, Kumar
    Kuppusamy, Umah Rani
    PARASITOLOGY RESEARCH, 2010, 106 (04) : 941 - 945
  • [29] Inhibitory action of berberine on colorectal cancer HCT116 cells by regulation of Hedgehog signaling pathway
    SUN Qiang
    CHEN Li
    ZENG Sha
    LIU Mao-lun
    REN Shan
    ZHAO Hui
    YANG Han
    MING Tian-qi
    LU Jin-jian
    XU Hai-bo
    中国药理学与毒理学杂志, 2021, 35 (10) : 771 - 772
  • [30] Licochalcone C Inhibits the Growth of Human Colorectal Cancer HCT116 Cells Resistant to Oxaliplatin
    Lee, Seung-On
    Joo, Sang Hoon
    Lee, Jin-Young
    Kwak, Ah-Won
    Kim, Ki-Taek
    Cho, Seung-Sik
    Yoon, Goo
    Choi, Yung Hyun
    Park, Jin Woo
    Shim, Jung-Hyun
    BIOMOLECULES & THERAPEUTICS, 2024, 32 (01) : 104 - 114